"As a leading authority in the field of genomics, our mission is to accelerate scientific and medical breakthroughs that improve human health. We do this by driving cutting-edge research, developing new technologies, and studying the impact of genomics on society."

During the past decade, National Human Genome Research Institute (NHGRI), 9000 Rockville Pike conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Human Genome Research Institute (NHGRI), 9000 Rockville Pike" #1 collaborator was "University of Virginia" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "National Human Genome Research Institute (NHGRI), 9000 Rockville Pike" are "Breast Cancer" (2 trials), "Cancer Genetics" (2 trials), "Congenital Heart Disease" (2 trials), "Diabetes" (2 trials) and "Genetics" (2 trials). Many other conditions were trialed in "National Human Genome Research Institute (NHGRI), 9000 Rockville Pike" in a lesser frequency.

The vast majority of trials in "National Human Genome Research Institute (NHGRI), 9000 Rockville Pike" are 37 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "National Human Genome Research Institute (NHGRI), 9000 Rockville Pike". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in National Human Genome Research Institute (NHGRI), 9000 Rockville Pike, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in National Human Genome Research Institute (NHGRI), 9000 Rockville Pike, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".